The artemisia annua plant, also known as sweet wormwood, has long provided a key ingredient in treating malaria The World Health Organization (WHO) is to test a malaria drug on Covid patients ...

Researchers in the United States have shown that extracts of an aromatic herb called Artemisia annua inhibit the replication of severe acute respiratory coronavirus (SARS-CoV-2) – the agent ...

Artemisia annua, known commonly as sweet wormwood, sweet Annie, and qinghao, is a shrub native to China long used both ornamentally and for medicinal purposes.

Artemisia annua is celebrated for its production of artemisinin, a powerful antimalarial agent. Although its glandular secretory trichomes have been the focus of extensive research, a complete ...

Still, some aren’t willing to give up on A. annua as a source of COVID-19 treatments. In April, California biotech company Mateon Therapeutics announced in a press release that tests showed ...

Produced in the specialised glandular trichomes of Artemisia annua, its biosynthesis is a multi‐step process mediated by enzymes such as amorpha-4,11-diene synthase and specific cytochrome P450 ...

Growing Artemisia annua and producing and testing the tablets, Weathers noted, are ideal local business that can provide jobs in impoverished areas and greatly expand access to antimalarial therapy.

Initially, several extracts of Artemisia annua and artemisinin were screened for antiviral activity using a plaque-reduction assay in VeroE6 cells (i.e., a specific type of an African green monkey ...

A derivative of the Artemisia annua plant, also known as sweet wormwood, has long been used in the treatment of malaria. Scientists are currently testing the plant’s potential against the novel ...

Artemisinin is a chemical compound in a traditional Chinese herb called Artemisia annua, or sweet wormwood. Some research suggests that it may show promise in future cancer treatments. Research ...